Visiongain has estimated that the total market for Isoxaflutole would be around $x million in 2020 and is projected to grow at a CAGR of x% during the forecast period 2021-2031. Factors such as increased food demand particularly in developing regions, increased investments in research and development and increasing plantations of soy and maize are driving the global market in Isoxaflutols and increasing quality. Factors such as lack of awareness of Isoxaflutole phytotoxicity limit the market.
Isoxaflutole Market – Our new market research study shows trends, developments, progress in R&D and forecast revenue till 2031. The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
Isoxaflutole is used to improve the quality and yields of soy and maize, as isoxaflutole protects chlorophyll from sunlight degradation in crops, which drives very long market growth. Increasing demand for food has seen a high demand in herbicides, which helps to gain higher demand for isoxaflutole due to the demographic dynamics in India , China and other emerging markets. A major driving factor for the global isoxaflutole market is expected for development in the global herbicide sector. The European Food safety agency ‘s increasing response to the use of isoxaflutol in other crops estimates that Isoxaflutol quickly degrades when used but its breakdown is gradually degrading in the sole. The lack of awareness of isoxaflutol phytotoxicity in Herbicides should remain a major problem for participants in the market, however.
What are the key factors to reshaping the growth of the Isoxaflutole market? To find out, you must read this newly updated report if you are one of the stake holder of this market. This exclusive report by Visiongain shows you potential revenue opportunity pool until 2031 for the assessment of data, trends, opportunities and business outlooks.
What factors could lead to an expansion of the Isoxaflutole market?
Increasing R&D in companies can offer new opportunities for companies working in the global isoxaflutol market to tackle these problems with the increase in soil pollution concerns. Isoxaflutole segment analysis: The sugar cane industry accounted for over 43% of its market share of 2019 as the highest propellant segment in each segment of the crop. In isoxaflutol research and development in the short term, the growing agro-cultural sector is expected to show high demand. Sugar cane is a major vegetable crop that is widely consumed worldwide for different purposes. As the crop segment represents 90% of the sugar cane market growth, it will hold about 45% of its market share between 2021 and 2031.
Is Herbicide Sector Driving the Global Isoxaflutols Market?
The growth of the global herbicide sector will continue to be a key driver for the global market in isoxaflutols. Increasing demand for food has been reflected in the increase in herbicide consumption, in turn complimented by isoxaflutol demand, due to demographic dynamics in China , India and other emerging markets. Isoxaflutole is used to enhance the quality and production of maize and soy because it protects chlorophyll in cultivation against sunlight degradation. More intervention by the European Food Safety Authority to boost isoxaflutole use in other crops should quickly give the market opportunities to develop isoxaflutole quickly, but its disintegration product slowly degrades in the soil. There will be a major challenge in market participants to continue to be lacking sensitization regarding the phytotoxicity of isoxaflutole in herbicides. Increasing R&D by companies in order to overcome such challenges in view of rising concerns regarding soil pollution may open up new possibilities for companies operating in the global isoxaflutole market.
What regions are the champions of Isoxaflutole market growth?
Regional Asia Pacific will dominate the Isoxaflutole market and, as a result of the presence of phenomenal key actors in the market, will grow by x.35% during the predicted period at CAGR. The major contributors to the market growth in Isoxaflutole in Asia Pacific are developed regions like India, China , and Japan, as a result of the leading sugar cane producer. Due to their high maize cultivation, the United States is recognised as the leading consumer of isoxaflutol in North America. The aim of the report is to present an overview of the global market for isoxaflutole, including all the industry’s stakeholders. The report with the analysis of complicated data in simple language presents the industry’s past and present status with predicted market sizes and trends.
Discover how to stay ahead
152 tables and graphs are included in our 250 page report. Read about the most lucrative industries and the future prospects on the market. Our new study allows you to evaluate forecast sales worldwide and regional. See financial results, trends, opportunities and forecasts of revenue. In this growing Isoxaflutole market a lot of opportunity remains. See how opportunities can be taken advantage of.
Forecasts to 2031 and other analyses reveal the commercial prospects of Isoxaflutole Market
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the Isoxaflutole market and submarkets
Global Isoxaflutole Market by Crop Type
Sugarcane
Maize
Apple
Peach
Almonds
Others crop type
Global Isoxaflutole Market by End-User
Industries
Agriculture
Others End-user
Global Isoxaflutole Market by Form
Granular
Liquid
Aerosol
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America Isoxaflutole Market Outlook
o U.S. Isoxaflutole Market Forecast & COVID Impact Analysis
o Canada Isoxaflutole Market Forecast & COVID Impact Analysis
• Europe Isoxaflutole Market Outlook
o Germany Isoxaflutole Market Forecast & COVID Impact Analysis
o France Isoxaflutole Market Forecast & COVID Impact Analysis
o United Kingdom Isoxaflutole Market Forecast & COVID Impact Analysis
o Italy Isoxaflutole Market Forecast & COVID Impact Analysis
o Spain Isoxaflutole Market Forecast & COVID Impact Analysis
o Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Isoxaflutole Market Outlook
o China Isoxaflutole Market Forecast & COVID Impact Analysis
o Japan Isoxaflutole Market Forecast & COVID Impact Analysis
o India Isoxaflutole Market Forecast & COVID Impact Analysis
o Australia Isoxaflutole Market Forecast & COVID Impact Analysis
o South Korea Isoxaflutole Market Forecast & COVID Impact Analysis
o Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• Latin America Isoxaflutole Market Outlook Market Forecast & COVID Impact Analysis
o Brazil Isoxaflutole Market Forecast & COVID Impact Analysis
o Mexico Isoxaflutole Market Forecast & COVID Impact Analysis
o Argentina Isoxaflutole Market Forecast & COVID Impact Analysis
o Rest of Latin America Market Forecast & COVID Impact Analysis
• Middle East and Africa Isoxaflutole Market Outlook
o Turkey Isoxaflutole Market Forecast & COVID Impact Analysis
o Saudi Arabia Isoxaflutole Market Forecast & COVID Impact Analysis
o South Africa Isoxaflutole Market Forecast & COVID Impact Analysis
o UAE Isoxaflutole Market Forecast & COVID Impact Analysis
o Egypt Isoxaflutole Market Forecast & COVID Impact Analysis
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Isoxaflutole Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Shanghai sinorgreatland industrial co, ltd
Shenzhen King Quenson Idustry co, ltd
Shijiazhuang Awiner Biotechnology ltd
Hangzhou kingtai chemicals co.ltd
Bayer CropScience and DuPont
Santa Cruz Biotechnology Ltd
Wanko Chemical Co. Ltd
E-tong chemical co.ltd
Jiaozuo Huisell co, ltd
Chemos GmbH
Overall world revenue for Isoxaflutole Market will surpass $x million in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Isoxaflutole Market report helps you
In summary, our 200+ page report provides you with the following knowledge:
• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?
• Revenue forecasts to 2031 for Isoxaflutole Market, with forecasts for Crop Type, End-User, Form, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the Isoxaflutole market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Isoxaflutole Market.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Isoxaflutole Market Report to 2031: By Crop Type: (Sugarcane, Maize, Apple, Peach, Almonds, Others crop type) On the basis of End-Users (Industries, Agriculture, Others End-user) On the basis of Form (Granular, Liquid, Aerosol) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped, W-shaped, U-shaped, L-shaped) Profiles of Leading Companies, Region and Country . Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Isoxaflutole Market
2.1. Isoxaflutole Market Definition
2.2. Industry Terms Used in the Isoxaflutole Market
2.3. Global Isoxaflutole Market Characteristics
2.4. Global Isoxaflutole Purchasers Analysis
2.5. Which are the Channels of distribution for Isoxaflutole?
2.6. How Isoxaflutole is Geographically distributed?
2.7. What are Supply and demand considerations for Isoxaflutole?
2.8. What is the Status of Global Supply of Isoxaflutole?
2.9. How much Demand for Isoxaflutole in the Global Market?
2.10. Which are the Substitutability Issues for Isoxaflutole?
2.11. What is the Lead times for Isoxaflutole?
2.12. Isoxaflutole Industry Knowledge of Country Sources
2.13. Which are the Factors Affecting Purchasing Decisions?
2.14. Comparisons of domestic products, subject imports, and non-subject imports
2.15. Comparison of Global Produced and Imported Isoxaflutole
2.16. What are Elasticity Estimates for Isoxaflutole?
2.17. Global Isoxaflutole Supply Elasticity
2.18. Global Isoxaflutole Demand Elasticity
2.19. Isoxaflutole Substitution Elasticity
3. What are the key factors reshaping the growth of the Isoxaflutole market?
3.1. Global Isoxaflutole Market Size and Forecast by Region
3.2. Global Isoxaflutole Market Share by Region
3.3. Market Dynamics
3.3.1. What are the Drivers Likely to Lead Market Growth?
3.3.1.1. A major driving factor for the global isoxaflutole market is expected for development in the global herbicide sector
3.3.1.2. Increasing demand for food has seen a high demand in herbicides
3.3.2. Which Factors Will Hinder Growth of Isoxaflutole Market?
3.3.2.1. International regulations for Isoxaflutole
3.3.2.2. Low awareness about the product
3.3.3. How Companies Can Encash Opportunities in the Isoxaflutole Market?
3.3.3.1. Increasing R&D in companies can offer new opportunities for companies working in the global isoxaflutol market to tackle these problems with the increase in soil pollution concerns
3.3.3.2. The major contributors to the market growth in Isoxaflutole in Asia Pacific are developed regions like India, China , and Japan, as a result of the leading sugar cane producer.
3.3.4. Global Isoxaflutole Market: Trends
3.3.4.1. The sugar cane industry accounted for over 43% of its market share of 2019 as the highest propellant segment in each segment of the crop
3.3.4.2. The growth of maize and soy crops in the United States should drive the regional demand for isoxaflutole.
3.3.5. SWOT Analysis of Isoxaflutole Market
3.3.5.1. What are the Strengths of the Isoxaflutole Market?
3.3.5.1.1. The growth of the global herbicide sector will continue to be a key driver for the global market in isoxaflutols
3.3.5.1.2. Isoxaflutole is used to enhance the quality and production of maize and soy
3.3.5.2. What are the Weaknesses of the Isoxaflutole Market?
3.3.5.2.1. Stringent international regulations
3.3.5.2.2. Consumer acceptance of the product
3.3.5.3. Which Opportunities Does Isoxaflutole Market Offers?
3.3.5.3.1. The large-scale U.S.-based maize and soya production of North America is a major consumer of isoxaflutole.
3.3.5.3.2. Agricultural growth is expected to boost demand
3.3.5.4. Which Threats to Watch in the Isoxaflutole Market?
3.3.5.4.1. Consistent performance of the product
3.3.5.4.2. Product substitution is the biggest threat
3.3.6. Porter’s Five Forces Analysis of Isoxaflutole Market
3.3.6.1. How Intense is the Competition in the Global Isoxaflutole Market?
3.3.6.2. Do Suppliers Have Power to Bargain?
3.3.6.3. How Buyer Can Play Power Game?
3.3.6.4. How to Tackle the Threat of Substitution in the Global Isoxaflutole Market?
3.3.6.5. How Innovations from New Players Will Pose Threats to Market Leaders?
4. Global Isoxaflutole Market Analysis and Forecast 2021-2031, by Crop Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Sugarcane
4.1.1. Total Land under Cultivation
4.1.2. Market Share of this Segment in the Global Market
4.1.3. Market Size Estimation and Forecast, 2021-2031
4.2. Maize
4.2.1. Total Land under Cultivation
4.2.2. Market Share of this Segment in the Global Market
4.2.3. Market Size Estimation and Forecast, 2021-2031
4.3. Apple
4.3.1. Total Land under Cultivation
4.3.2. Market Share of this Segment in the Global Market
4.3.3. Market Size Estimation and Forecast, 2021-2031
4.4. Peach
4.4.1. Total Land under Cultivation
4.4.2. Market Share of this Segment in the Global Market
4.4.3. Market Size Estimation and Forecast, 2021-2031
4.5. Almonds
4.5.1. Total Land under Cultivation
4.5.2. Market Share of this Segment in the Global Market
4.5.3. Market Size Estimation and Forecast, 2021-2031
4.6. Others crop type
4.6.1. Total Land under Cultivation
4.6.2. Market Share of this Segment in the Global Market
4.6.3. Market Size Estimation and Forecast, 2021-2031
5. Global Isoxaflutole Market Analysis and Forecast 2021-2031, by End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Industries
5.1.1. Trend Analysis of this Segment
5.1.2. Advantages and Disadvantages
5.1.3. Market Share Analysis
5.1.4. Market Estimation and Forecast, 2021-2031(COVID Impact Analysis)
5.2. Agriculture
5.2.1. Trend Analysis of this Segment
5.2.2. Advantages and Disadvantages
5.2.3. Market Share Analysis
5.2.4. Market Estimation and Forecast, 2021-2031(COVID Impact Analysis)
5.3. Others End-user
5.3.1. Trend Analysis of this Segment
5.3.2. Advantages and Disadvantages
5.3.3. Market Share Analysis
5.3.4. Market Estimation and Forecast, 2021-2031(COVID Impact Analysis)
6. Global Isoxaflutole Market Analysis and Forecast 2021-2031, by Product Form (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Granular
6.1.1. Global Supply Elasticity
6.1.2. Global Demand Elasticity
6.1.3. Substitution Elasticity
6.1.4. Market Share Analysis
6.1.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
6.2. Liquid
6.2.1. Global Supply Elasticity
6.2.2. Global Demand Elasticity
6.2.3. Substitution Elasticity
6.2.4. Market Share Analysis
6.2.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
6.3. Aerosol
6.3.1. Global Supply Elasticity
6.3.2. Global Demand Elasticity
6.3.3. Substitution Elasticity
6.3.4. Market Share Analysis
6.3.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
7. North America Isoxaflutole Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Isoxaflutole Market Size and Forecast by Crop Type
7.2.1. Sugarcane Submarket Expected to Grow at Fastest Rate
7.3. North America Isoxaflutole Market Size and Forecast by End-User
7.3.1. Agriculture Submarket to Grow at Fastest Rate
7.4. North America Isoxaflutole Market Size and Forecast by Product Form
7.4.1. Granular Submarket to Grow at Fastest Rate
7.5. U.S. Isoxaflutole Market
7.5.1. Isoxaflutole Production, Capacity, And Capacity Utilization
7.5.2. Isoxaflutole Pricing Trend Analysis
7.5.3. Which factors will hinder the growth of the Isoxaflutole market?
7.5.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
7.6. Canada Isoxaflutole Market
7.6.1. Isoxaflutole Production, Capacity, And Capacity Utilization
7.6.2. Isoxaflutole Pricing Trend Analysis
7.6.3. Which factors will hinder the growth of the Isoxaflutole market?
7.6.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8. Europe Isoxaflutole Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Isoxaflutole Market Size and Forecast by Crop Type
8.2.1. Sugarcane Submarket Expected to Grow at Fastest Rate
8.3. Europe Isoxaflutole Market Size and Forecast by End-User
8.3.1. Agriculture Submarket to Grow at Fastest Rate
8.4. Europe Isoxaflutole Market Size and Forecast by Product Form
8.4.1. Granular Submarket to Grow at Fastest Rate
8.5. UK Isoxaflutole Market
8.5.1. Isoxaflutole Production, Capacity, And Capacity Utilization
8.5.2. Isoxaflutole Pricing Trend Analysis
8.5.3. Which factors will hinder the growth of the Isoxaflutole market?
8.5.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8.6. Germany Isoxaflutole Market
8.6.1. Isoxaflutole Production, Capacity, And Capacity Utilization
8.6.2. Isoxaflutole Pricing Trend Analysis
8.6.3. Which factors will hinder the growth of the Isoxaflutole market?
8.6.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8.7. France Isoxaflutole Market
8.7.1. Isoxaflutole Production, Capacity, And Capacity Utilization
8.7.2. Isoxaflutole Pricing Trend Analysis
8.7.3. Which factors will hinder the growth of the Isoxaflutole market?
8.7.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8.8. Italy Isoxaflutole Market
8.8.1. Isoxaflutole Production, Capacity, And Capacity Utilization
8.8.2. Isoxaflutole Pricing Trend Analysis
8.8.3. Which factors will hinder the growth of the Isoxaflutole market?
8.8.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8.9. Spain Isoxaflutole Market
8.9.1. Isoxaflutole Production, Capacity, And Capacity Utilization
8.9.2. Isoxaflutole Pricing Trend Analysis
8.9.3. Which factors will hinder the growth of the Isoxaflutole market?
8.9.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8.10. Rest of Europe Isoxaflutole Market
8.10.1. Isoxaflutole Production, Capacity, And Capacity Utilization
8.10.2. Isoxaflutole Pricing Trend Analysis
8.10.3. Which factors will hinder the growth of the Isoxaflutole market?
8.10.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
9. Asia Pacific Isoxaflutole Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Isoxaflutole Market Size and Forecast by Crop Type
9.2.1. Sugarcane Submarket Expected to Grow at Fastest Rate
9.3. Asia-Pacific Isoxaflutole Market Size and Forecast by End-User
9.3.1. Agriculture Submarket to Grow at Fastest Rate
9.4. Asia-Pacific Isoxaflutole Market Size and Forecast by Product Form
9.4.1. Granular Submarket to Grow at Fastest Rate
9.5. China Isoxaflutole Market
9.5.1. Isoxaflutole Production, Capacity, And Capacity Utilization
9.5.2. Isoxaflutole Pricing Trend Analysis
9.5.3. Which factors will hinder the growth of the Isoxaflutole market?
9.5.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
9.6. India Isoxaflutole Market
9.6.1. Isoxaflutole Production, Capacity, And Capacity Utilization
9.6.2. Isoxaflutole Pricing Trend Analysis
9.6.3. Which factors will hinder the growth of the Isoxaflutole market?
9.6.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
9.7. Japan Isoxaflutole Market
9.7.1. Isoxaflutole Production, Capacity, And Capacity Utilization
9.7.2. Isoxaflutole Pricing Trend Analysis
9.7.3. Which factors will hinder the growth of the Isoxaflutole market?
9.7.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
9.8. Rest of Asia Pacific Isoxaflutole Market
9.8.1. Isoxaflutole Production, Capacity, And Capacity Utilization
9.8.2. Isoxaflutole Pricing Trend Analysis
9.8.3. Which factors will hinder the growth of the Isoxaflutole market?
9.8.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
10. Latin America Isoxaflutole Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Isoxaflutole Market Size and Forecast by Crop Type
10.2.1. Sugarcane Submarket Expected to Grow at Fastest Rate
10.3. Latin America Isoxaflutole Market Size and Forecast by End-User
10.3.1. Agriculture Submarket to Grow at Fastest Rate
10.4. Latin America Isoxaflutole Market Size and Forecast by Product Form
10.4.1. Granular Submarket to Grow at Fastest Rate
10.5. Brazil Isoxaflutole Market
10.5.1. Isoxaflutole Production, Capacity, And Capacity Utilization
10.5.2. Isoxaflutole Pricing Trend Analysis
10.5.3. Which factors will hinder the growth of the Isoxaflutole market?
10.5.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
10.6. Mexico Isoxaflutole Market
10.6.1. Isoxaflutole Production, Capacity, And Capacity Utilization
10.6.2. Isoxaflutole Pricing Trend Analysis
10.6.3. Which factors will hinder the growth of the Isoxaflutole market?
10.6.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
10.6.5. Rest of Latin America Isoxaflutole Market
11. MEA Isoxaflutole Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Isoxaflutole Market Size and Forecast by Crop Type
11.2.1. Sugarcane Submarket Expected to Grow at Fastest Rate
11.3. MEA Isoxaflutole Market Size and Forecast by End-User
11.3.1. Agriculture Submarket to Grow at Fastest Rate
11.4. MEA Isoxaflutole Market Size and Forecast by Product Form
11.4.1. Granular Submarket to Grow at Fastest Rate
11.5. GCC Isoxaflutole Market
11.5.1. Isoxaflutole Production, Capacity, And Capacity Utilization
11.5.2. Isoxaflutole Pricing Trend Analysis
11.5.3. Which factors will hinder the growth of the Isoxaflutole market?
11.5.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
11.6. South Africa Isoxaflutole Market
11.6.1. Isoxaflutole Production, Capacity, And Capacity Utilization
11.6.2. Isoxaflutole Pricing Trend Analysis
11.6.3. Which factors will hinder the growth of the Isoxaflutole market?
11.6.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
11.7. Rest of MEA Isoxaflutole Market
11.7.1. Isoxaflutole Production, Capacity, And Capacity Utilization
11.7.2. Isoxaflutole Pricing Trend Analysis
11.7.3. Which factors will hinder the growth of the Isoxaflutole market?
11.7.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
12. Companies in the Isoxaflutole Market
12.1. Shanghai sinorgreatl and industrial co, ltd
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Developments (2017-2020)
12.2. Shenzhen King Quenson Idustry co, ltd
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Developments (2017-2020)
12.3. Shijiazhuang Awiner Biotechnology ltd
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Developments (2017-2020)
12.4. Hangzhou kingtai chemicals co.ltd
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Developments (2017-2020)
12.5. Bayer CropScience and DuPont
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Developments (2017-2020)
12.6. Santa Cruz Biotechnology Ltd
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Developments (2017-2020)
12.7. Wanko Chemical Co. Ltd
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Developments (2017-2020)
12.8. E-tong chemical co.ltd
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Developments (2017-2020)
12.9. Jiaozuo Huisell co, ltd
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Developments (2017-2020)
12.10. Chemos GmbH
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Developments (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 2. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Isoxaflutole Market Drivers & Restraints 2020
Table 7. Isoxaflutole Submarket Forecast by Value 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 8. Isoxaflutole Submarket Forecast by Value 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Isoxaflutole Submarket Forecast by Value 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Isoxaflutole Submarket Forecast by Value 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Isoxaflutole Submarket Forecast by Value 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 13. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 18. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 23. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 28. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Isoxaflutole Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 33. Isoxaflutole Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Isoxaflutole Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Isoxaflutole Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Isoxaflutole Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 38. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Maize Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 43. Maize Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Maize Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Maize Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Maize Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Apple Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 48. Apple Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Apple Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Apple Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Apple Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Peach Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 53. Peach Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Peach Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Peach Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Peach Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Almonds Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 58. Almonds Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Almonds Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Almonds Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Almonds Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Industries Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 63. Industries Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Industries Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Industries Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Industries Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 68. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Isoxaflutole Market Forecast by Product Form 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 73. Isoxaflutole Market Forecast by Product Form 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Isoxaflutole Market Forecast by Product Form 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Isoxaflutole Market Forecast by Product Form 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Isoxaflutole Market Forecast by Product Form 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Regional Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 78. Regional Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Regional Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Regional Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Regional Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 83. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 88. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 93. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 98. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. US Isoxaflutole Market Dynamics
Table 103. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 104. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Canada Isoxaflutole Market Dynamics
Table 109. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 110. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 111 Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 112. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 113. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 114. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 115. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 116. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 117. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 118. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 119. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 120. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 121. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 122. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 123. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 124. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 125. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 126. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 127. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 128. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 129. UK Isoxaflutole Market Dynamics
Table 130. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 131. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 132. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 133. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 134. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 135. Germany Isoxaflutole Market Dynamics
Table 136. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 137. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 138. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 139. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 140. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 141. France Isoxaflutole Market Dynamics
Table 142. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 143. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Asia Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 148. Asia Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Asia Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Asia Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Asia Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Asia Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 153. Asia Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Asia Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Asia Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Asia Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Asia Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 158. Asia Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Asia Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Asia Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Asia Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 162. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 163. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 164. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 165. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 166. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 167. China Isoxaflutole Market Dynamics
Table 168. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 169. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 170. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 171. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 172. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 173. India Isoxaflutole Market Dynamics
Table 174. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 175. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 176. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 177. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 178. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 179. Japan Isoxaflutole Market Dynamics
Table 180. RoAPAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 181. RoAPAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 182. RoAPAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 183. RoAPAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 184. RoAPAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 185. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 186. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 187. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 188. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 189. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 190. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 191. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 192. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 193. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 194. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 195. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 196. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 197. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 198. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 199. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 200. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 201. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 202. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 203. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 204. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 205. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 206. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 207. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 208. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 209. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 210. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 211. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 212. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 213. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 214. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 215. Leading 10 Isoxaflutole Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 216. Shanghai sinorgreatl and industrial co, ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 217. Shanghai sinorgreatl and industrial co, ltd Isoxaflutole Selected Recent Developments 2019 (Date, Development Type, Details)
Table 218. Shanghai sinorgreatl and industrial co, ltd Product Offering (Segment, Product Offerings)
Table 219. Shenzhen King Quenson Idustry co, ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 220. Shenzhen King Quenson Idustry co, ltd Product Offering (Segment, Product Offerings)
Table 221. Shijiazhuang Awiner Biotechnology ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 222 Shijiazhuang Awiner Biotechnology ltd Isoxaflutole Selected Recent Developments 2017-2019 (Date, Development Type, Details)
Table 223. Shijiazhuang Awiner Biotechnology ltd Product Offering (Segment, Product Offerings)
Table 224. Hangzhou kingtai chemicals co.ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 225. Hangzhou kingtai chemicals co.ltd Selected Recent Developments 2015-2019 (Date, Development Type, Details)
Table 226. Hangzhou kingtai chemicals co.ltd Product Offering (Segment, Product Offerings)
Table 227. Bayer CropScience and DuPont Profile 2020 (CEO, HQ, Founded, Website)
Table 228. Bayer CropScience and DuPont Product Offering (Segment, Product Offerings)
Table 229. Santa Cruz Biotechnology Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 230. Santa Cruz Biotechnology Ltd Selected Recent Developments 2015-2019 (Date, Development Type, Details)
Table 231. Santa Cruz Biotechnology Ltd Product Offering (Segment, Product Offerings)
Table 232. Wanko Chemical Co. Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 233. Wanko Chemical Co. Ltd Product Offering (Segment, Product Offerings)
Table 234. E-tong chemical co.ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 235. E-tong chemical co.ltd Product Offering (Segment, Product Offerings)
Table 236. Jiaozuo Huisell co, ltd, Inc Profile 2020 (CEO, HQ, Founded, Website)
Table 237. Jiaozuo Huisell co, ltd Product Offering (Segment, Product Offerings)
Table 238. Chemos GmbH Profile 2020 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 239. Chemos GmbH, Total Company Sales 2015-2019 (US$ Mn, AGR %)
Table 240. Chemos GmbH Sales by Segment of Business 2019 (US$ Mn)
Table 241. Chemos GmbH Sales by Regional Segment of Business 2019 (US$ Mn)
Table 242. Chemos GmbH Product Offering (Segment, Product Offerings)
Table 243. Other Companies Involved in the Isoxaflutole Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Isoxaflutole Market Crop Type Overview
Figure 2. Isoxaflutole Market End-User Overview
Figure 3. Isoxaflutole Market Product Form Overview
Figure 4. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 5. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 6. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 7. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 8. Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 9. Isoxaflutole Submarket Forecast by Crop Type 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 10. Isoxaflutole Submarket Forecast by Crop Type 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario V)
Figure 11. Isoxaflutole Submarket Forecast by Crop Type 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario U)
Figure 12. Isoxaflutole Submarket Forecast by Crop Type 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario W)
Figure 13. Isoxaflutole Submarket Forecast by Crop Type 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario L)
Figure 14. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Agriculture Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 16. Agriculture Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 17. Agriculture Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 18. Agriculture Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 19. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Others End-user Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 21. Others End-user Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 22. Others End-user Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 23. Others End-user Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 24. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 26. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 27. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 28. Granular Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 29. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 31. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 32. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 33. Liquid Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 34. Isoxaflutole Submarket Forecast by End-User 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 35. Isoxaflutole Submarket Forecast by End-User 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario V)
Figure 36. Isoxaflutole Submarket Forecast by End-User 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario U)
Figure 37. Isoxaflutole Submarket Forecast by End-User 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario W)
Figure 38. Isoxaflutole Submarket Forecast by End-User 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario L)
Figure 39. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 40. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario V)
Figure 41. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 42. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 43. Sugarcane Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 44. Maize Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 45. Maize Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario V)
Figure 46. Maize Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 47. Maize Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 48. Maize Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 49. Apple Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 50. Apple Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario V)
Figure 51. Apple Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 52. Apple Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 53. Apple Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 54. Peach Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 55. Peach Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 56. Peach Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 57. Peach Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 58. Peach Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 59. Almonds Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 60. Almonds Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario V)
Figure 61. Almonds Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 62. Almonds Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 63. Almonds Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 64. Industries Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 65. Industries Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario V)
Figure 66. Industries Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 67. Industries Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 68. Industries Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 69. Others Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 70. Others Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario V)
Figure 71. Others Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario U)
Figure 72. Others Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario W)
Figure 73. Others Submarket Forecast 2021-2031 (US$ Mn, Global AGR %) (COVID – Scenario L)
Figure 74. Isoxaflutole Submarket Forecast by Product Form 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 75. Isoxaflutole Submarket Forecast by Product Form 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario V)
Figure 76. Isoxaflutole Submarket Forecast by Product Form 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario U)
Figure 77. Isoxaflutole Submarket Forecast by Product Form 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario W)
Figure 78. Isoxaflutole Submarket Forecast by Product Form 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario L)
Figure 79. Regional Isoxaflutole Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 80. Regional Isoxaflutole Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 81. Regional Isoxaflutole Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 82. Regional Isoxaflutole Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 83. Regional Isoxaflutole Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 84. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 85. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 86. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 87. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 88. North America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 89. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %)
Figure 90. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 91. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 92. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 93. North America Isoxaflutole Market Forecast by End-User 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 94. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 95. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 96. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 97. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 98. North America Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 99. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 100. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 101. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 102. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 103. US Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 104. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %)
Figure 105. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 106. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 107. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 108. Canada Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 109. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M)
Figure 110. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario V)
Figure Maize. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 112. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 113. Europe Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 114. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (Before COVID)
Figure 115. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario V)
Figure 116. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario U)
Figure 117. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario W)
Figure 118. Europe Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario L)
Figure 119. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (Before COVID)
Figure 120. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario V)
Figure 121. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario U)
Figure 122. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario W)
Figure 123. Europe Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario L)
Figure 124. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 125. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 126. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID – Scenario U)
Figure 127. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 128. UK Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 129. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %)
Figure 130. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 131. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 132. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 133. Germany Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 134. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %)
Figure 135. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 136. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 137. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 138. France Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 139. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 140. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 141. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 142. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 143. Rest of Europe Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 144. Asia-Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (Before COVID)
Figure 145. Asia-Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 146. Asia-Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 147. Asia-Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 148. Asia-Pacific Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 149. Asia-Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$M)
Figure 150. Asia-Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario V)
Figure 151. Asia-Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario U)
Figure 152. Asia-Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario W)
Figure 153. Asia-Pacific Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario L)
Figure 154. Asia-Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 155. Asia-Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario V)
Figure 156. Asia-Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario U)
Figure 157. Asia-Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario W)
Figure 158. Asia-Pacific Isoxaflutole Market Forecast by Country 2021-2031 (US$ Mn, Global AGR %) (COVID - Scenario L)
Figure 159. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %)
Figure 160. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 161. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 162. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 163. China Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 164. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %)
Figure 165. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 166. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 167. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 168. India Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 169. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 170. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 171. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 172. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 173. Japan Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 174. Rest of APAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (Before COVID)
Figure 175. Rest of APAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario V)
Figure 176. Rest of APAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario U)
Figure 177. Rest of APAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario W)
Figure 178. Rest of APAC Isoxaflutole Market Forecast 2021-2031 (US$ Mn, AGR %) (COVID - Scenario L)
Figure 179. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M)
Figure 180. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 181. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 182. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 183. Middle East Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 184. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$M)
Figure 185. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario V)
Figure 186. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario U)
Figure 187. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario W)
Figure 188. Middle East Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario L)
Figure 189. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M)
Figure 190. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 191. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 192. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 193. Latin America Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 194. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$M)
Figure 195. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario V)
Figure 196. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario U)
Figure 197. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario W)
Figure 198. Latin America Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario L)
Figure 199. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M)
Figure 200. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 201. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 202. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 203. Africa Isoxaflutole Market Forecast by Crop Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 204. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (Before COVID)
Figure 205. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario V)
Figure 206. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario U)
Figure 207. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario W)
Figure 208. Africa Isoxaflutole Market Forecast by End-User 2021-2031 (US$M) (COVID - Scenario L)
Figure 209. Porter’s Five Force Analysis
Figure 210. Chemos GmbH Total Company Sales 2015-2019 (US$m, AGR %)
Figure 211. Chemos GmbH Sales by Segment of Business 2019 (US$m)
Figure 212. Chemos GmbH Sales by Regional Segment of Business 2019 (US$m)
Profiles of Key Players in Isoxaflutole market
Shanghai sinorgreatland industrial co, ltd
Shenzhen King Quenson Idustry co, ltd
Shijiazhuang Awiner Biotechnology ltd
Hangzhou kingtai chemicals co.ltd
Bayer CropScience and DuPont
Santa Cruz Biotechnology Ltd
Wanko Chemical Co. Ltd
E-tong chemical co.ltd
Jiaozuo Huisell co, ltd
Chemos GmbH
Other Companies Mentioned in the Report
E. I. du Pont de Nemours and Company
Aventis CropScience
Zhejiang Corechem
Syngenta
Marrone Bio Innovation
Arysta LifeScience Corporation
FMC Corporation
Adama Agricultural Solutions Ltd.
Koppert Biological Systems
Kumiai Chemical Industry Co., Ltd.
Marrone Bio Innovations
Nissan Chemical
Nutrichem Company Ltd. (Beijing Nutrichem)
Shandong Weifang Rainbow Chemical Co., Ltd.
UPL
Nippon Soda
Platform Specialty Products Corporation
The Mosaic Company
EuroChem Group AG
Yara International ASA
Natural Industries
Valent Biosciences.
PI Industries
Cheminova
Vendors covered
Vendor classification
Rotam CropScience
List of Organizations relate to Isoxaflutole market
Agrochemicals Association of Kenya (AAK)
Agribusiness Association of Iowa
Kentucky Fertilizer & Agriculture Chemical Association
South Carolina Fertilizer and Agrichemical Association
The Agricultural Retailers Association (ARA)
National Association of Chemical Distributors
American Composites Manufacturing Association
NASS Agricultural Chemical
The Council of Producers & Distributors of Agrotechnology
Canadian Agricultural Chemicals Association
The Agricultural Retailers Association
The Agricultural Chemicals Industry Association (ACIA)
Society of Chemical Manufacturers and Affiliates
Society of Chemical Manufacturers & Affiliates (SOCMA)
Premier Agricultural Industry Association
Chemical Association (MACA)
Japan Crop Protection Association (JCPA)
Missouri Agribusiness Association
Tennessee Agricultural Chemical Association (TACA)
Florida Fertilizer & Agrichemical Association
New England Agricultural Chemical Association
KFCA - Kansas Fertilizer and Chemical Association (agriculture)
American Agricultural Economics Association
Japan Plant Protection Association.
West Texas Agricultural Chemicals Institute
Illinois Fertilizer & Chemical Association
Aceto Agricultural Chemicals Corporation
Visiongain Chemicals
Visiongain Chemicals
Visiongain Chemicals
